Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

NCT04309656 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Multi-drug Resistant Tuberculosis

Interventions

DRUG: Pretomanid

Sponsor

Global Alliance for TB Drug Development